Astonea Labs IPO is to open on May 27, 2025. It is a SME IPO that will raise ₹37.67 crores. The Astonea Labs Services IPO price band is fixed at ₹128 to ₹135 with a market lot of 1000 Shares.
Astonea Labs IPO opens for subscription on May 27, 2025 and closes on May 29, 2025. The allotment for the Astonea Labs IPO is expected to be finalized on Friday, May 30, 2025. Astonea Labs IPO will be list on BSE SME with a tentative listing date fixed as Tuesday, June 3, 2025.
Astonea Labs IPO price band is set at ₹128 to ₹135 per share. The minimum lot size for an application is 1000. The minimum amount of investment required by retail investors is ₹1,28,000. But it is suggested to the investor to bid at the cutoff price to avoid the oversubscription senerio, which is about to ₹1,35,000. The minimum lot size investment for HNI is 2 lots (2,000 shares) amounting to ₹2,70,000.
Astonea Labs IPO Ltd is a trusted manufacturing company and has over 35 years of experience in the industry. It’s based in Haryana, India. They are proud of their strong focus on customer satisfaction and ability to offer flexible manufacturing solutions that help clients grow and succeed. They work mainly as a quality-focused third-party manufacturer, producing a wide range of pharmaceutical and cosmetic products. These include tablets, capsules, softgels, powders, ointments, creams, and lotions, all made to meet strict Drug and Cosmetics industry standards. Astonea Labs’ goal is to consistently provide high-quality products that support and improve the lives of people around the world.
Refer to Astonea Labs IPO Details IPO RHP for detailed information. (Additionally, keep checking back here for additional information about newipo.info or anything else.)
Astonea Labs IPO Details
| IPO Date | May 27, 2025 to May 29, 2025 |
| Listing Date | [.] |
| Face Value | ₹10 per share |
| Issue Price Band | ₹128 to ₹135 per share |
| Lot Size | 1,000 Shares |
| Total Issue Size | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| Fresh Issue | 27,90,000 shares (aggregating up to ₹37.67 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 77,21,000 shares |
| Share Holding Post Issue | 1,05,11,000 shares |
| Market Maker Portion | 1,44,000 shares |
Astonea Labs IPO Reservation
| Investor Category | Shares Offered |
|---|---|
| QIB Shares Offered | Not more than 50% of the Net Issue |
| Retail Shares Offered | Not less than 35% of the Net Issue |
| NII (HNI) Shares Offered | Not less than 15% of the Net Issue |
Astonea Labs IPO Timeline (Tentative Schedule)
Astonea Labs IPO opens on May 27, 2025, and closes on May 29, 2025.
| IPO Open Date | Tue, May 27, 2025 |
| IPO Close Date | Thu, May 29, 2025 |
| Tentative Allotment | Fri, May 30, 2025 |
| Initiation of Refunds | Mon, Jun 2, 2025 |
| Credit of Shares to Demat | Mon, Jun 2, 2025 |
| Tentative Listing Date | Tue, Jun 3, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on May 29, 2025 |
Astonea Labs IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1000 | ₹1,35,000 |
| Retail (Max) | 1 | 1000 | ₹1,35,000 |
| HNI (Min) | 2 | 2,000 | ₹2,70,000 |
| Lot Size Calculator | |||
Astonea Labs IPO Promoter Holding
Ashish Gulati is the promoter of the company.
| Share Holding Pre Issue | 98.42% |
| Share Holding Post Issue |
Astonea Labs Ltd Financial Information (Restated)
| Period Ended | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
| Assets | 96.52 | 80.89 | 64.28 | 52.91 |
| Revenue | 69.69 | 80.29 | 67.26 | 30.17 |
| Profit After Tax | 4.10 | 3.81 | 0.67 | 0.25 |
| Net Worth | 17.28 | 11.97 | 8.16 | 7.49 |
| Reserves and Surplus | 9.56 | 4.37 | 4.16 | 3.49 |
| Total Borrowing | 49.48 | 42.40 | 35.99 | 29.52 |
| Amount in ₹ Crore | ||||
About Astonea Labs Ltd
Incorporated in 2017, Astonea Labs Ltd. is engaged in contract manufacturing of pharmaceutical and cosmetic products for companies both within India and internationally.
The company manufactures and markets a variety of pharmaceutical and cosmetic products, including antibiotics, anti-cold medicines, antihistamines, and treatments for diabetes, heart, gynecological issues, infections, and more.
The company offers skin, tooth, and hair care products in forms like gels, creams, and serums, and also trades packaging and raw materials for pharmaceutical and cosmetic industries, meeting industry standards.
The company engages in contract manufacturing of pharmaceutical and cosmetic products, markets its own brands "Glow Up" and "Regero," plans to launch "Avicel," and exports to countries like Iraq and Yemen.
Produts and Offerings:
- Products under our own brands: The company markets “Glow Up” skincare and “Regero” pharma products, offering diverse affordable solutions.
- Products under contract manufacturing: The company provides pharmaceutical and cosmetic products under contract manufacturing, primarily for domestic and export markets.
As of August 16, 2024, the company had 217 employees on payroll.
Competitive Strengths:
- Experienced management and dedicated employee base
- Scalable business model
- Wide and diverse range of product offerings
- Quality Service